X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
LEP has formulated a line of products including CANNAVERA™, a family of topical pain relief products currently pending for over-the-counter (OTC) registration with the FDA.
Lead Product(s): Cannabis Sativa,Eugenia Caryophyllus Flower Oil,Rosmarinus Officinalis Leaf Extract
Therapeutic Area: Neurology Product Name: Cannavera
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Evio Labs
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition July 12, 2021
Details:
Edge Pharma has signed an agreement with ANI Pharmaceuticals to market the company's FDA approved Vancomycin Hydrochloride for Oral Solution USP, a generic equivalent to Vancocin®.
Lead Product(s): Vancomycin Hydrochloride
Therapeutic Area: Gastroenterology Product Name: Vancomycin Hydrochloride-Generic
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: ANI Pharmaceuticals Inc
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement June 25, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
